Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Russian Journal of Pediatric Hematology and OncologyOpen Access

Radiation therapy to metastatic sites among patients with high-risk neuroblastoma in first-line therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

ТSТ. V. ShamanskayaYVYu. M. VoevodinaAUA. Yu. Usychkina

Discussion

Loading...

Member takes

Overview

Retrospective analysis shows improved survival with radiation therapy for metastatic sites in high-risk neuroblastoma, indicating potential for local control.

Key Points

  • Radiation therapy enhanced survival in patients with high-risk neuroblastoma and metastatic foci during treatment.
  • Three-year overall survival was reported at 80% among patients receiving radiation therapy for metastasis.
  • Retrospective analysis of 11 high-risk neuroblastoma patients showed significant engagement in combined treatment protocols.
  • The findings suggest radiation therapy could play a key role in managing metastasis, but require larger studies to validate.

Cite This Study

Shamanskaya et al. (2025) studied this question.

synapsesocial.com/papers/68c23e02b210217d6478fdc5https://doi.org/10.21682/2311-1267-2025-12-1-27-38
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Isolated leptomeningeal relapses in high-risk neuroblastoma2025
  2. 2Intensification of postconsolidation therapy in patients with high-risk neuroblastoma2024
  3. 3OS06.1.A INTRAOPERATIVE RADIOTHERAPY AFTER RESECTION OF BRAIN METASTASES (INTRAMET)- FINAL RESULTS OF A PROSPECTIVE, SINGLE-ARM, OPEN-LABEL PHASE 2 TRIAL2025
  4. 4Re-irradiation in Children With Recurrent Medulloblastoma.2025 · 1 citations
  5. 5Radiation for high-risk asymptomatic bone metastases – an implementation science perspective2025